Categories: News

The Real Smoke Screen: How The Ismokay App Is Helping Users Quit Smoking Through Behavioral Changes Amidst COVID

LOS ANGELES, Dec. 11, 2020 /PRNewswire-PRWeb/ — In the modern age, it is widely understood that smoking is unhealthy and can cause serious health complications, but the age-old question remains: what is the best way to quit? Due to scientific and technological advances over time, there are deeper insights into the habit of smoking and the physical and mental factors associated with it. Over the years there have been theories circulating over the best method to quit, but there has never been a reliable resource where smokers can seek help, motivation, and support; until now. Introducing Ismokay: the new one-of-a-kind app using behavioral change to help users quit smoking.

As the COVID-19 pandemic continues on, the human race has been force to adopt new habits, and abandon others. Social distancing, masks, and quarantines have become commonplace in this covid-era, but the shift is coincidentally helping individuals break bad habits. Many smokers claim they only smoke casually, but casual gatherings are becoming scarce and even taboo. Many smokers regularly hold a cigarette while outside in public, but now masks have become mandatory and this practice has become less common. Due to this, the pandemic has actually played a positive role in helping users fight the urge to pick up a pack of smokes.

Ismokay, has jumped in to push that initiative further and help users quit for good. This unique methodology uses specific journeys and behavioral changes, scientifically proven to create a lasting and meaningful change for those who commit to the process. Users of Ismokay will have the ability to:

  • Implement healthy habits to counteract smoking
  • Have access to guidelines for changing habits
  • Track their cigarette consumption, creating tables and visual representations of current and past smoking habits
  • Weekly guidance and motivation to stay on the right track
  • Select behavioral changes specific to each user to create a realistic and attainable goal in the journey to quit smoking for good

Through proof of concept, dedication to the methodology, and unwavering commitment to helping their users create lasting change; Ismokay’s purpose-driven vision has come to fruition with the launch of this revolutionary mobile app set to change the face of the tobacco industry.

To learn more about Ismokay, please visit: https://ismokay.com/en/methodology/

About Ismokay

Ismokay is a mobile app created and dedicated to smokers in all paths of life. From the conscious smoker who wants to cut back, to those who need the motivation to keep the habit away, the Ismokay methodology involves the concept of behavioral changes, scientifically proven in several studies to help cut back or quit smoking altogether. By focusing on creating healthy habits at both the physical and emotional level, users of Ismokay can shift their behavior and take the “mind over matter” concept to fruition.

Media Contact

Hannah Spraker, Ismokay, +1 6476382940, press@ismokay.com

 

SOURCE Ismokay

Staff

Recent Posts

Glow Lifetech Grants Stock Options

Toronto, Ontario--(Newsfile Corp. - December 27, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

4 hours ago

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

RA'ANANA, Israel, Dec. 27, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN), (NASDAQ:…

4 hours ago

In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI

CHONGQING, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Stock Code: BGM) has successfully acquired…

4 hours ago

NAVIGANTIS VASCO™ Robotic Platform Used with First Patients Enrolled in Neurovascular Study

MIAMI, Dec. 27, 2024 /PRNewswire/ -- Navigantis Inc. announced today the first successful neurovascular clinical cases…

4 hours ago

Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand

Company Receives Capital Needed from its Term Lender and Existing Investors to Reach Profitability without…

4 hours ago

Vor Bio Announces $55.6 Million Private Placement

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the…

7 hours ago